Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.

BACKGROUND: Despite the growing interest in immunotherapeutic interventions for endometrial cancer (EC), the prevalence, phenotype, specificity and prognostic value of tumor infiltrating lymphocytes (TILs) in this tumor type remains unclear. METHODS: To better understand the role of TILs in EC, we a...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomero, Jara, Panisello, Carla, Lozano-Rabella, Maria, Tirtakasuma, Ricky, Díaz-Gómez, Judit, Grases, Daniela, Pasamar, Helena, Arregui, Laura, Dorca Duch, Eduard, Guerra Fernández, Esther, Vivancos, Ana, de Andrea, Carlos E, Melero, Ignacio, Ponce, Jordi, Vidal, August, Piulats, Josep Maria, Matias-Guiu, Xavier, Gros, Alena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806064/
https://www.ncbi.nlm.nih.gov/pubmed/36581331
http://dx.doi.org/10.1136/jitc-2022-005443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806064/
https://www.ncbi.nlm.nih.gov/pubmed/36581331
http://dx.doi.org/10.1136/jitc-2022-005443

Ejemplares similares